Health
Mutant gene-targeted immunotherapy approach developed – Medical Xpress
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy…
A novel targeted immunotherapy approach developed by researchers at the Ludwig Center, the Lustgarten Laboratory, and Bloomberg-Kimmel Institute for Cancer Immunotherapy at the Johns Hopkins Kimmel Cancer Center employs new antibodies against genetically altered proteins to target cancers.
The researchers targeted their immunotherapy approach to alterations in the common cancer-related p53 tumor suppressor gene, the RAS tumor-promoting oncogene or T-cell receptor genes. They also tested the therapy…
-
Business12 hours ago1 ASX dividend stock down 43% I’d buy right now
-
General22 hours agoCoalition abandons ‘end’ to work from home, walks back 41,000 job cuts
-
Noosa News12 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business15 hours ago5 things to watch on the ASX 200 on Monday 7 April 2025